Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Burkitt Lymphoma 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Leukemia, Biphenotypic, Acute 7Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Myeloid, Acute 3Leukemia, Myeloid, Accelerated Phase 3Blast Crisis 3Lymphoma, Mantle-Cell 2Down Syndrome 2Blastic Plasmacytoid Dendritic Cell Neoplasm 2Renal Pelvis and Ureter Urothelial Carcinoma 1Osteosarcoma 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Carcinoma 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Cyclophosphamide 7fludarabine phosphate 6Whole-Body Irradiation 6Busulfan 5Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Melphalan 4Azacitidine 4venetoclax 3fludarabine 3Tacrolimus 3Cyclosporine 3Biopsy 3Vorinostat 2Specimen Handling 2Rituximab 2Methotrexate 2Etoposide 2Cytarabine 2Antilymphocyte Serum 2thymoglobulin 1pegylated granulocyte colony-stimulating factor 1merphos 1ivosidenib 1decitabine and cedazuridine drug combination 1cedazuridine 1Thiotepa 1TAK-243 1Stem Cell Transplantation 1Sirolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anemia, Refractory, with Excess of Blasts × merphos × 90 days × Clear all
NCT02220985 2026-06-01

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

Fred Hutchinson Cancer Center

Phase 2 Completed
84 enrolled 22 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡